However, with few exceptions, such as histone deacetylase 6 and hexokinase-264–66, even those particularly likely druggable target candidates have so far not been studied in depth in context of their potential role in, and impact on, infections with SARS-CoV-2 or other coronaviruses. Here, HDAC6 is linked to infection.